Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10184 | 1020 | 26.8 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
574 | 13610 | STRUMA OVARII//OVARIAN CANCER//OVARIAN NEOPLASMS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BORDERLINE OVARIAN TUMOR | Author keyword | 67 | 67% | 6% | 60 |
2 | ENDOSALPINGIOSIS | Author keyword | 49 | 66% | 5% | 46 |
3 | BORDERLINE OVARIAN TUMORS | Author keyword | 47 | 64% | 5% | 47 |
4 | BORDERLINE OVARIAN TUMOUR | Author keyword | 44 | 100% | 2% | 16 |
5 | LOW MALIGNANT POTENTIAL | Author keyword | 37 | 59% | 4% | 41 |
6 | ENDOCERVICOSIS | Author keyword | 32 | 80% | 2% | 20 |
7 | BORDERLINE TUMOR | Author keyword | 27 | 47% | 4% | 42 |
8 | FERTILITY SPARING SURGERY | Author keyword | 24 | 45% | 4% | 39 |
9 | MULLERIANOSIS | Author keyword | 19 | 71% | 1% | 15 |
10 | INVASIVE IMPLANTS | Author keyword | 17 | 100% | 1% | 8 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BORDERLINE OVARIAN TUMOR | 67 | 67% | 6% | 60 | Search BORDERLINE+OVARIAN+TUMOR | Search BORDERLINE+OVARIAN+TUMOR |
2 | ENDOSALPINGIOSIS | 49 | 66% | 5% | 46 | Search ENDOSALPINGIOSIS | Search ENDOSALPINGIOSIS |
3 | BORDERLINE OVARIAN TUMORS | 47 | 64% | 5% | 47 | Search BORDERLINE+OVARIAN+TUMORS | Search BORDERLINE+OVARIAN+TUMORS |
4 | BORDERLINE OVARIAN TUMOUR | 44 | 100% | 2% | 16 | Search BORDERLINE+OVARIAN+TUMOUR | Search BORDERLINE+OVARIAN+TUMOUR |
5 | LOW MALIGNANT POTENTIAL | 37 | 59% | 4% | 41 | Search LOW+MALIGNANT+POTENTIAL | Search LOW+MALIGNANT+POTENTIAL |
6 | ENDOCERVICOSIS | 32 | 80% | 2% | 20 | Search ENDOCERVICOSIS | Search ENDOCERVICOSIS |
7 | BORDERLINE TUMOR | 27 | 47% | 4% | 42 | Search BORDERLINE+TUMOR | Search BORDERLINE+TUMOR |
8 | FERTILITY SPARING SURGERY | 24 | 45% | 4% | 39 | Search FERTILITY+SPARING+SURGERY | Search FERTILITY+SPARING+SURGERY |
9 | MULLERIANOSIS | 19 | 71% | 1% | 15 | Search MULLERIANOSIS | Search MULLERIANOSIS |
10 | INVASIVE IMPLANTS | 17 | 100% | 1% | 8 | Search INVASIVE+IMPLANTS | Search INVASIVE+IMPLANTS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PERITONEAL IMPLANTS | 188 | 83% | 10% | 105 |
2 | SEROUS TUMORS | 78 | 70% | 6% | 65 |
3 | CRIBRIFORM PATTERNS | 52 | 80% | 3% | 32 |
4 | MICROPAPILLARY | 48 | 71% | 4% | 39 |
5 | MICROINVASION | 33 | 52% | 5% | 46 |
6 | BORDERLINE TUMORS | 25 | 27% | 8% | 78 |
7 | BENIGN GLANDULAR INCLUSIONS | 23 | 72% | 2% | 18 |
8 | EPITHELIAL TUMORS | 22 | 19% | 10% | 104 |
9 | STROMAL MICROINVASION | 18 | 89% | 1% | 8 |
10 | MALIGNANT POTENTIAL TUMORS | 17 | 75% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Management of borderline ovarian neoplasms | 2007 | 85 | 45 | 93% |
Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence | 2012 | 21 | 72 | 86% |
Conservative treatment of early stage ovarian cancer: Oncological and fertility outcomes | 2014 | 6 | 32 | 59% |
Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options | 2013 | 11 | 108 | 76% |
Fertility-Sparing Surgery in Ovarian Cancer Extended beyond the Ovaries: A Case Report and Review of the Literature | 2014 | 3 | 11 | 91% |
Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology About the Conservative Management of Ovarian Malignant Tumors | 2011 | 20 | 80 | 80% |
Borderline tumours of the ovary and fertility | 2006 | 53 | 62 | 92% |
Conservative surgery for borderline ovarian tumors: A review | 2006 | 67 | 59 | 73% |
Histologic distribution of borderline ovarian tumors worldwide: a systematic review | 2013 | 4 | 53 | 87% |
Benign Epithelial Inclusions in Axillary Lymph Nodes: Report of 18 Cases and Review of the Literature | 2011 | 13 | 34 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FRAUEN POLIKLIN | 4 | 75% | 0.3% | 3 |
2 | U10 30 | 2 | 50% | 0.3% | 3 |
3 | UNIV HOSP AMIENS | 1 | 50% | 0.2% | 2 |
4 | FRAUENGESUNDHEIT | 1 | 40% | 0.2% | 2 |
5 | KLIN FRAUENHEILKUNDE GEBURTSMED | 1 | 33% | 0.2% | 2 |
6 | REFERENZZENTRUM GYNAKOPATHOL | 1 | 33% | 0.2% | 2 |
7 | CANC FEMME RECH CLIN | 1 | 50% | 0.1% | 1 |
8 | E LAUDER BREAST IMAGING | 1 | 50% | 0.1% | 1 |
9 | FLOOR S 1 | 1 | 50% | 0.1% | 1 |
10 | GRP CHIRURG | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000227592 | PSAMMOCARCINOMA//PSAMMOMA BODIES//PRIMARY PERITONEAL CARCINOMA |
2 | 0.0000204218 | ARID1A//CLEAR CELL CARCINOMA//OVARIAN CLEAR CELL CARCINOMA |
3 | 0.0000153642 | RISK OF MALIGNANCY INDEX//ADNEXAL MASSES//ADNEXAL MASS |
4 | 0.0000123984 | BRENNER TUMOR//MALIGNANT BRENNER TUMOR//BRENNER TUMOUR |
5 | 0.0000102478 | OVARIAN CARCINOMAS//CANC MONTREAL//6Q27 |
6 | 0.0000100540 | FERTILITY DRUGS//OVARIAN NEOPLASMS//INCESSANT OVULATION |
7 | 0.0000098900 | INTERVAL DEBULKING SURGERY//SECONDARY CYTOREDUCTIVE SURGERY//ADVANCED OVARIAN CANCER |
8 | 0.0000092269 | KRUKENBERG TUMOR//OVARIAN METASTASIS//OVARIAN METASTASES |
9 | 0.0000078340 | GIANT OVARIAN CYST//OVARIAN NEOPLASY//SKIN PLASTY |
10 | 0.0000072957 | PRIMARY FALLOPIAN TUBE CARCINOMA//FALLOPIAN TUBE CARCINOMA//OVARIAN DYSPLASIA |